135 related articles for article (PubMed ID: 25897830)
21. Synergism between the mTOR inhibitor rapamycin and FAK down-regulation in the treatment of acute lymphoblastic leukemia.
Shi PJ; Xu LH; Lin KY; Weng WJ; Fang JP
J Hematol Oncol; 2016 Feb; 9():12. PubMed ID: 26892465
[TBL] [Abstract][Full Text] [Related]
22. Concurrent inhibition of PI3K and mTORC1/mTORC2 overcomes resistance to rapamycin induced apoptosis by down-regulation of Mcl-1 in mantle cell lymphoma.
Müller A; Zang C; Chumduri C; Dörken B; Daniel PT; Scholz CW
Int J Cancer; 2013 Oct; 133(8):1813-24. PubMed ID: 23580240
[TBL] [Abstract][Full Text] [Related]
23. Torin2 Potentiates Anticancer Effects on Adult T-Cell Leukemia/Lymphoma by Inhibiting Mammalian Target of Rapamycin.
Watanabe T; Sato A; Kobayashi-Watanabe N; Sueoka-Aragane N; Kimura S; Sueoka E
Anticancer Res; 2016 Jan; 36(1):95-102. PubMed ID: 26722032
[TBL] [Abstract][Full Text] [Related]
24. Cutaneous T-cell lymphoma cells are sensitive to rapamycin.
Kremer M; Sliva K; Klemke CD; Schnierle BS
Exp Dermatol; 2010 Sep; 19(9):800-5. PubMed ID: 20629739
[TBL] [Abstract][Full Text] [Related]
25. Chronic hypoxia-induced alterations of key enzymes of glucose oxidative metabolism in developing mouse liver are mTOR dependent.
Dukhande VV; Sharma GC; Lai JC; Farahani R
Mol Cell Biochem; 2011 Nov; 357(1-2):189-97. PubMed ID: 21625955
[TBL] [Abstract][Full Text] [Related]
26. Rapamycin Impairs Antitumor CD8+ T-cell Responses and Vaccine-Induced Tumor Eradication.
Chaoul N; Fayolle C; Desrues B; Oberkampf M; Tang A; Ladant D; Leclerc C
Cancer Res; 2015 Aug; 75(16):3279-91. PubMed ID: 26122844
[TBL] [Abstract][Full Text] [Related]
27. Oridonin inhibits mTOR signaling and the growth of lung cancer tumors.
Wang YY; Lv YF; Lu L; Cai L
Anticancer Drugs; 2014 Nov; 25(10):1192-200. PubMed ID: 25075795
[TBL] [Abstract][Full Text] [Related]
28. Reversal of Warburg Effect and Reactivation of Oxidative Phosphorylation by Differential Inhibition of EGFR Signaling Pathways in Non-Small Cell Lung Cancer.
De Rosa V; Iommelli F; Monti M; Fonti R; Votta G; Stoppelli MP; Del Vecchio S
Clin Cancer Res; 2015 Nov; 21(22):5110-20. PubMed ID: 26216352
[TBL] [Abstract][Full Text] [Related]
29. Targeting mTOR/p70S6K/glycolysis signaling pathway restores glucocorticoid sensitivity to 4E-BP1 null Burkitt Lymphoma.
Gu L; Xie L; Zuo C; Ma Z; Zhang Y; Zhu Y; Gao J
BMC Cancer; 2015 Jul; 15():529. PubMed ID: 26189041
[TBL] [Abstract][Full Text] [Related]
30. Downregulation of cancer stem cell properties via mTOR signaling pathway inhibition by rapamycin in nasopharyngeal carcinoma.
Yang C; Zhang Y; Zhang Y; Zhang Z; Peng J; Li Z; Han L; You Q; Chen X; Rao X; Zhu Y; Liao Z
Int J Oncol; 2015 Sep; 47(3):909-17. PubMed ID: 26202311
[TBL] [Abstract][Full Text] [Related]
31. Marked activity of irinotecan and rapamycin combination toward colon cancer cells in vivo and in vitro is mediated through cooperative modulation of the mammalian target of rapamycin/hypoxia-inducible factor-1alpha axis.
Pencreach E; Guérin E; Nicolet C; Lelong-Rebel I; Voegeli AC; Oudet P; Larsen AK; Gaub MP; Guenot D
Clin Cancer Res; 2009 Feb; 15(4):1297-307. PubMed ID: 19190131
[TBL] [Abstract][Full Text] [Related]
32. mTORC1-Dependent Metabolic Reprogramming Underlies Escape from Glycolysis Addiction in Cancer Cells.
Pusapati RV; Daemen A; Wilson C; Sandoval W; Gao M; Haley B; Baudy AR; Hatzivassiliou G; Evangelista M; Settleman J
Cancer Cell; 2016 Apr; 29(4):548-562. PubMed ID: 27052953
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of Aerobic Glycolysis Represses Akt/mTOR/HIF-1α Axis and Restores Tamoxifen Sensitivity in Antiestrogen-Resistant Breast Cancer Cells.
Woo YM; Shin Y; Lee EJ; Lee S; Jeong SH; Kong HK; Park EY; Kim HK; Han J; Chang M; Park JH
PLoS One; 2015; 10(7):e0132285. PubMed ID: 26158266
[TBL] [Abstract][Full Text] [Related]
34. mTORC1 inhibitors suppress meningioma growth in mouse models.
Pachow D; Andrae N; Kliese N; Angenstein F; Stork O; Wilisch-Neumann A; Kirches E; Mawrin C
Clin Cancer Res; 2013 Mar; 19(5):1180-9. PubMed ID: 23406776
[TBL] [Abstract][Full Text] [Related]
35. Differentiation of human neuroblastoma cells toward the osteogenic lineage by mTOR inhibitor.
Carpentieri A; Cozzoli E; Scimeca M; Bonanno E; Sardanelli AM; Gambacurta A
Cell Death Dis; 2015 Nov; 6(11):e1974. PubMed ID: 26561783
[TBL] [Abstract][Full Text] [Related]
36. Focal adhesion kinase-promoted tumor glucose metabolism is associated with a shift of mitochondrial respiration to glycolysis.
Zhang J; Gao Q; Zhou Y; Dier U; Hempel N; Hochwald SN
Oncogene; 2016 Apr; 35(15):1926-42. PubMed ID: 26119934
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of mTOR activity restores tamoxifen response in breast cancer cells with aberrant Akt Activity.
deGraffenried LA; Friedrichs WE; Russell DH; Donzis EJ; Middleton AK; Silva JM; Roth RA; Hidalgo M
Clin Cancer Res; 2004 Dec; 10(23):8059-67. PubMed ID: 15585641
[TBL] [Abstract][Full Text] [Related]
38. Metformin Targets Mitochondrial Glycerophosphate Dehydrogenase to Control Rate of Oxidative Phosphorylation and Growth of Thyroid Cancer
Thakur S; Daley B; Gaskins K; Vasko VV; Boufraqech M; Patel D; Sourbier C; Reece J; Cheng SY; Kebebew E; Agarwal S; Klubo-Gwiezdzinska J
Clin Cancer Res; 2018 Aug; 24(16):4030-4043. PubMed ID: 29691295
[No Abstract] [Full Text] [Related]
39. Non-metabolic functions of glycolytic enzymes in tumorigenesis.
Yu X; Li S
Oncogene; 2017 May; 36(19):2629-2636. PubMed ID: 27797379
[TBL] [Abstract][Full Text] [Related]
40. β-alanine suppresses malignant breast epithelial cell aggressiveness through alterations in metabolism and cellular acidity in vitro.
Vaughan RA; Gannon NP; Garcia-Smith R; Licon-Munoz Y; Barberena MA; Bisoffi M; Trujillo KA
Mol Cancer; 2014 Jan; 13():14. PubMed ID: 24460609
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]